This is a preview of subscription content, log in via an institution to check access.
Reference
Alkan A, et al. Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (≥ 75) patients. Journal of Men's Health 17: 128-134, No. 4, Jan 2021. Available from: URL: http://www.jomh.org/index.php/JMH
Rights and permissions
About this article
Cite this article
Abiraterone-acetate. Reactions Weekly 1893, 15 (2022). https://doi.org/10.1007/s40278-022-09798-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-09798-6